{"title":"Anaphylaxis due to progesterone hypersensitivity: A rare cause of recurrent anaphylaxis.","authors":"Van Khanh Bui, Thi Trinh Cao, Hong Ngoc Nguyen","doi":"10.5415/apallergy.0000000000000247","DOIUrl":null,"url":null,"abstract":"<p><p>Progesterone hypersensitivity (PH) is a rare but underrecognized cause of recurrent anaphylaxis in women, particularly those of reproductive age. Both endogenous and exogenous progesterone can trigger hypersensitivity reactions, with clinical presentations ranging from urticaria to life-threatening anaphylaxis. We report a case of a 33-year-old Vietnamese woman who experienced six episodes of unexplained anaphylaxis over two years. A thorough clinical history revealed exposure to intramuscular progesterone during in vitro fertilization cycles and cyclical vulvar skin eruptions before menstruation. Skin prick testing with injectable progesterone was negative, while intradermal testing produced a positive reaction, confirming the diagnosis of PH. The patient was thoroughly counseled regarding her condition and equipped with an epinephrine auto-injector alongside a written anaphylaxis action plan. Daily antihistamine therapy with levocetirizine was initiated to mitigate the risk of endogenous progesterone-induced reactions. Given her stable condition and sterilization history, no further hormonal intervention was required. During two years of follow-up, she remained asymptomatic, with no recurrence of anaphylaxis. This case highlights the importance of considering PH in the differential diagnosis of recurrent anaphylaxis in women, especially those with cyclical allergic symptoms or a history of exogenous progesterone exposure. Early recognition and appropriate management are crucial to prevent potentially life-threatening events.</p>","PeriodicalId":8488,"journal":{"name":"Asia Pacific Allergy","volume":"16 2","pages":"138-140"},"PeriodicalIF":2.8000,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13060776/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Asia Pacific Allergy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5415/apallergy.0000000000000247","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/11/10 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"ALLERGY","Score":null,"Total":0}
引用次数: 0
Abstract
Progesterone hypersensitivity (PH) is a rare but underrecognized cause of recurrent anaphylaxis in women, particularly those of reproductive age. Both endogenous and exogenous progesterone can trigger hypersensitivity reactions, with clinical presentations ranging from urticaria to life-threatening anaphylaxis. We report a case of a 33-year-old Vietnamese woman who experienced six episodes of unexplained anaphylaxis over two years. A thorough clinical history revealed exposure to intramuscular progesterone during in vitro fertilization cycles and cyclical vulvar skin eruptions before menstruation. Skin prick testing with injectable progesterone was negative, while intradermal testing produced a positive reaction, confirming the diagnosis of PH. The patient was thoroughly counseled regarding her condition and equipped with an epinephrine auto-injector alongside a written anaphylaxis action plan. Daily antihistamine therapy with levocetirizine was initiated to mitigate the risk of endogenous progesterone-induced reactions. Given her stable condition and sterilization history, no further hormonal intervention was required. During two years of follow-up, she remained asymptomatic, with no recurrence of anaphylaxis. This case highlights the importance of considering PH in the differential diagnosis of recurrent anaphylaxis in women, especially those with cyclical allergic symptoms or a history of exogenous progesterone exposure. Early recognition and appropriate management are crucial to prevent potentially life-threatening events.
期刊介绍:
Asia Pacific Allergy (AP Allergy) is the official journal of the Asia Pacific Association of Allergy, Asthma and Clinical Immunology (APAAACI). Although the primary aim of the journal is to promote communication between Asia Pacific scientists who are interested in allergy, asthma, and clinical immunology including immunodeficiency, the journal is intended to be available worldwide. To enable scientists and clinicians from emerging societies appreciate the scope and intent of the journal, early issues will contain more educational review material. For better communication and understanding, it will include rational concepts related to the diagnosis and management of asthma and other immunological conditions. Over time, the journal will increase the number of original research papers to become the foremost citation journal for allergy and clinical immunology information of the Asia Pacific in the future.